Tata Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 07, 2025.
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts less than Nifty Smallcap 250 and 1.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Tata Chemicals' Board approved audited consolidated and standalone results for Q4 and FY25 (ended March 31, 2025), with auditor BSR & Co. LLP issuing an unmodified opinion. Consolidated revenue from operations declined to ₹14,887 crore in FY25 from ₹15,421 crore in FY24, a drop of about 3.5%. Net profit fell to ₹387 crore from ₹435 crore, while Q4 FY25 standalone results showed a loss of ₹49 crore. The company booked exceptional charges of ₹125 crore toward closure costs of the Lostock Soda Ash plant in the UK, following last year's ₹963 crore UK impairment. Operating margin compressed sharply from 12.11% to 5.58%, and interest coverage weakened from 5.37x to 3.47x. The Board recommended a final dividend of ₹11 per share (110%) for FY25, lower than ₹15 (150%) in FY24, and approved raising up to ₹200 crore via term loans and/or NCDs on a private placement basis.
Mixed-to-weak for shareholders: full-year revenue and profit declined, UK operations are being wound down with additional closure costs, and the dividend was cut. However, the auditor sign-off is clean, operating cash flows remain healthy at ~₹1,761 crore, and the modest debt raise (₹200 crore) is small relative to the balance sheet, limiting near-term dilution or solvency concerns.